IL10 and nasopharyngeal carcinoma: failed to discern statistically significant changes in serum IL-10 concentrations among healthy controls and NPC patients pre/posttreatment, suggesting the localized expression of IL-10, primarily within the TME, without substantial systemic secretion (75).